← FDA Drug Approvals (Drugs@FDA)

CABENUVA KIT

NDA · New Drug Application · Sponsor: VIIV HLTHCARE · Approved 2021-01-21

Drug application

FDA Application #

NDA212888

Application type

New Drug Application

Brand name

CABENUVA KIT

Generic name

CABOTEGRAVIR AND RILPIVIRINE

Active ingredients

CABOTEGRAVIR; RILPIVIRINE

Dosage form

SUSPENSION, EXTENDED RELEASE

Route

INTRAMUSCULAR

Marketing status

Prescription

Sponsor

VIIV HLTHCARE

Manufacturer

ViiV Healthcare Company

First approval

2021-01-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown